AKT1 and metabolic syndrome: Insulin-related signaling pathways such as IRS/PI3K/AKT/GLUT4, IRS/PI3K/GSK, MAPK/ERK, and PI3K/Akt/GSK play important roles in the development of metabolic syndrome associated with abnormal glucolipid metabolism.